EORTC Cancer Research Fund
Help drive critical clinical cancer research and give hope to patients and loved ones.
The European Organisation for Research and Treatment of Cancer (EORTC) is an
academic clinical research organisation, which unites cancer research
experts across the globe to define better treatments for patients to prolong survival and improve quality of life. Both international and multidisciplinary, EORTC’s network comprises of over 3,800 members involved in cancer treatment and research in more than 1,000 institutions across 58 countries. Conducting translational research, and phase 2 and 3 trials, EORTC offers an integrated approach to therapeutic strategies and quality of life. EORTC Headquarters, a unique international clinical research infrastructure, are based in Brussels, Belgium, from where its various activities are coordinated and run.
EORTC pushes the boundaries of treatment options to improve patient care. Spanning all cancer types and treatments as well as working across borders, we are currently engaged in 150 trials at distinct stages of development including several practice-changing trials.
The EORTC Cancer Research Fund (ECRF) is the funding arm of this scientific organization with a mission to promote, encourage and support research on the treatment of cancer under the auspices of the EORTC. Unlike commercially driven research, ECRF supports academic clinical cancer research that prioritises therapeutic progress for patients—not profit.
